SCHEMBL4013265

SCHEMBL4013265

CC(=O)C(c1ccc2ncccc2c1)C1CCN(Cc2ccccc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 1/20 0.45
CXCR4 P61073 1/20 0.45
MCHR1 Q99705 1/20 0.45
ACHE P22303 2/20 0.45
DRD2 P14416 2/20 0.45
DRD4 P21917 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
ALDH1A1 P00352 2/20 0.44
LMNA P02545 2/20 0.44
CHKA P35790 1/20 0.44
ABL1 P00519 1/20 0.44
RIN1 Q13671 1/20 0.44
GMNN O75496 1/20 0.43
HPGD P15428 1/20 0.43
DRD3 P35462 1/20 0.43
PMP22 Q01453 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
OGA O60502 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4287276 0.81 MCHR1 (0.41) MCHR1ACHEDRD2DRD4ABL1
SCHEMBL4287391 0.81 HRH3 (0.42) ACKR3CXCR4MCHR1ACHEDRD2
SCHEMBL4289984 0.80 BCHE (0.61) ACKR3ACHEDRD2DRD4SMN1; SMN2
SCHEMBL7501907 0.80 ABL1 (0.54) ACHEABL1RIN1SIGMAR1
Hydrochloric Acid SCHEMBL9385815 0.79 BCHE (0.61) ACKR3ACHEDRD2DRD4SMN1; SMN2
SCHEMBL3404965 0.74 DRD2 (0.56) ACHEDRD2DRD4SMN1; SMN2CHKA
SCHEMBL220037 0.73 ACHE (0.66) ACHESIGMAR1
SCHEMBL4284931 0.72 DRD4 (0.45) ACHEDRD2DRD4ABL1RIN1
SCHEMBL4284930 0.72 BCHE (0.52) ACHESMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL9381131 0.71 ACHE (0.48) ACHESMN1; SMN2ALDH1A1HPGDSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009085226-A2 INHIBITORS OF CDC2-LIKE KINASES (CLKS) AND METHODS OF USE THEREOF SIRTRIS PHARMACEUTICALS, INC. (US) 2009-07-09 WO disclosed
EP-1853610-A1 N-PHENYL BENZAMIDE DERIVATIVES AS SIRTUIN MODULATORS Sirtris Pharmaceuticals, Inc. (US) 2007-11-14 EP disclosed
EP-1850840-A2 NOVEL COMPOSITIONS FOR PREVENTING AND TREATING NEURODEGENERATIVE AND BLOOD COAGULATION DISORDERS Sirtris Pharmaceuticals, Inc. (US) 2007-11-07 EP disclosed
WO-2006094236-A1 N-PHENYL BENZAMIDE DERIVATIVES AS SIRTUIN MODULATORS SIRTRIS PHARMACEUTICALS, INC. (US) 2006-09-08 WO disclosed
WO-2006076681-A2 NOVEL COMPOSITIONS FOR PREVENTING AND TREATING NEURODEGENERATIVE AND BLOOD COAGULATION DISORDERS SIRTRIS PHARMACEUTICALS, INC. (US) 2006-07-20 WO disclosed